title: TORCH study: how much longer should we continue to use erlotinib in unselected patients with non-small-cell lung cancer?
authors.forename: Vito
authors.initials: V
authors.lastname: Lorusso
authors.forename: Nicola
authors.initials: N
authors.lastname: Silvestris
authors.forename: Ilaria
authors.initials: I
authors.lastname: Marech
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male